Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Parkinson Disease ll: Pathophysiology

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...

Mitochondria

Mitochondria

Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...

Mitochondrial Precursor Proteins

Mitochondrial Precursor Proteins

Mitochondrial precursors are partially unfolded or loosely folded polypeptide chains. Newly synthesized precursors are inhibited from spontaneously folding into their native conformation by the cytosolic chaperones, heat shock proteins 70 (Hsp70), and mitochondrial import stimulation factors (MSFs). Precursors bound to MSFs are guided to the TOM70-TOM37 receptors, while precursors bound to Hsp70 chaperones are targetted to TOM20-TOM22 receptor complexes.
Most of the mitochondrial precursors...

Alzheimer Disease ll: Pathophysiology

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...

Electron Transport Chain: Complex I and II

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Patient cerebral organoids capture Alzheimer's disease proteomic biomarkers and drug targets.

bioRxiv : the preprint server for biology·2026

Same author

Evaluating the causal effect of mitochondrial dysfunction on Alzheimer's disease and Parkinson's disease using polygenic risk scores and Mendelian randomization.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026

Same author

An aging hallmark, Alzheimer's disease, and <i>APOE</i> nexus.

Journal of Alzheimer's disease : JAD·2026

Same author

Limbic-predominant neuroimaging correlates of plasma p-Tau217 in preclinical and clinical Alzheimer's disease.

Frontiers in aging neuroscience·2026

Same author

Downward bias in the association between APOE and Alzheimer's disease using prevalent and by-proxy disease sampling in the All of Us research program.

BMC medical genomics·2026

Same author

Structural signature of plasma proteins classifies the status of Alzheimer's disease.

Nature aging·2026

Search research articles

Related Experiment Video

Updated: Jun 22, 2026

Using Live Cell STED Imaging to Visualize Mitochondrial Inner Membrane Ultrastructure in Neuronal Cell Models

Using Live Cell STED Imaging to Visualize Mitochondrial Inner Membrane Ultrastructure in Neuronal Cell Models

Published on: June 30, 2023

The neurodegenerative mitochondriopathies.

Russell H Swerdlow¹

¹Department of Neurology, University of Kansas School of Medicine, Kansas City, KS 66160, USA. rswerdlow@kumc.edu

Journal of Alzheimer'S Disease : JAD

|June 23, 2009

Summary

Mitochondrial dysfunction is a common factor in neurodegenerative diseases, including Alzheimer's and Parkinson's. This review unifies these conditions under the term "neurodegenerative mitochondriopathies," highlighting shared mitochondrial abnormalities.

More Related Videos

Histological Examination of Mitochondrial Morphology in a Parkinson's Disease Model

Histological Examination of Mitochondrial Morphology in a Parkinson's Disease Model

Published on: June 23, 2023

Assessing Mitochondrial Function in Sciatic Nerve by High-Resolution Respirometry

Assessing Mitochondrial Function in Sciatic Nerve by High-Resolution Respirometry

Published on: May 5, 2022

Related Experiment Videos

Last Updated: Jun 22, 2026

Using Live Cell STED Imaging to Visualize Mitochondrial Inner Membrane Ultrastructure in Neuronal Cell Models

Using Live Cell STED Imaging to Visualize Mitochondrial Inner Membrane Ultrastructure in Neuronal Cell Models

Published on: June 30, 2023

Histological Examination of Mitochondrial Morphology in a Parkinson's Disease Model

Histological Examination of Mitochondrial Morphology in a Parkinson's Disease Model

Published on: June 23, 2023

Assessing Mitochondrial Function in Sciatic Nerve by High-Resolution Respirometry

Assessing Mitochondrial Function in Sciatic Nerve by High-Resolution Respirometry

Published on: May 5, 2022

Area of Science:

Neuroscience
Cell Biology
Genetics

Background:

Mitochondrial alterations are observed in both rare and common neurodegenerative diseases like Alzheimer's and Parkinson's.
These changes can manifest as specific functional deficits or systemic mitochondrial dysfunction.
The etiology of these disorders varies, involving mitochondrial DNA mutations, nuclear gene mutations, or unknown causes.

Purpose of the Study:

To classify neurodegenerative diseases based on mitochondrial dysfunction.
To define a unifying category of disorders termed "neurodegenerative mitochondriopathies."
To review known mitochondrial abnormalities and their connection to neurodegeneration.

Main Methods:

Literature review and synthesis of existing research on mitochondrial dysfunction in neurodegenerative diseases.
Classification of diseases based on shared mitochondrial pathology.
Discussion of the mitochondria-neurodegeneration nexus.

Main Results:

Identified common patterns of mitochondrial abnormalities across diverse neurodegenerative conditions.
Established "neurodegenerative mitochondriopathies" as a unifying classification.
Highlighted the significant role of mitochondrial dysfunction in diseases not traditionally considered mitochondrial.

Conclusions:

Mitochondrial dysfunction serves as a unifying feature for a broad spectrum of neurodegenerative diseases.
The concept of neurodegenerative mitochondriopathies provides a new framework for understanding and potentially treating these conditions.
Further research into the mitochondria-neurodegeneration nexus is crucial for understanding disease mechanisms and developing targeted therapies.